Himanshu Soni, E. Antonio Chiocca, Joshua D. Bernstock
{"title":"抗生素推动溶瘤病毒疗法的发展","authors":"Himanshu Soni, E. Antonio Chiocca, Joshua D. Bernstock","doi":"10.1038/s41551-024-01269-5","DOIUrl":null,"url":null,"abstract":"Oncolytic viruses expressing transgenes for immunomodulatory cytokines can be produced at high throughput by exploiting the preferential susceptibility of the viruses to certain antibiotics.","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"15 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibiotic-driven boosting of oncolytic virotherapy\",\"authors\":\"Himanshu Soni, E. Antonio Chiocca, Joshua D. Bernstock\",\"doi\":\"10.1038/s41551-024-01269-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Oncolytic viruses expressing transgenes for immunomodulatory cytokines can be produced at high throughput by exploiting the preferential susceptibility of the viruses to certain antibiotics.\",\"PeriodicalId\":19063,\"journal\":{\"name\":\"Nature Biomedical Engineering\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":26.8000,\"publicationDate\":\"2024-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Biomedical Engineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1038/s41551-024-01269-5\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-024-01269-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Antibiotic-driven boosting of oncolytic virotherapy
Oncolytic viruses expressing transgenes for immunomodulatory cytokines can be produced at high throughput by exploiting the preferential susceptibility of the viruses to certain antibiotics.
期刊介绍:
Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.